LEADER 00989nam0-2200301 --450 
001 9910419659503321
005 20211122154020.0
010   $a978-88-495-4277-6
100   $a20201009d2020----kmuy0itay5050    ba
101 0 $aita
102   $aIT
105   $a        001yy
200 1 $aGiudici consequenzialisti$ela modulazione temporale degli effetti delle pronunce tra efficacia ultra partes ed effettivitą della tutela$fValentina Capasso
210   $aNapoli$cEdizioni Scientifiche Italiane$d2020
215   $a277 p.$d24 cm
225 1 $aQuaderni de Il giusto processo civile$v15
700  1$aCapasso,$bValentina$0765897
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910419659503321
952   $aVIII F 79$b507 cos$fDDCIC
952   $aBB-432$b109-20 (a)$fDDRC
952   $aBB-432 BIS$b109-20 (b)$fDDRC
952   $aBB-432 TER$b109-20 (c)$fDDRC
959   $aDDCIC
959   $aDDRC
996   $aGiudici consequenzialisti$91758637
997   $aUNINA

LEADER 03068nam  2200733Ia 450 
001 9911019332203321
005 20200520144314.0
010   $a9786612188275
010   $a9781118679470
010   $a1118679474
010   $a9781282188273
010   $a1282188275
010   $a9780470459416
010   $a0470459417
010   $a9780470459409
010   $a0470459409
035   $a(CKB)1000000000773866
035   $a(EBL)448903
035   $a(SSID)ssj0000336032
035   $a(PQKBManifestationID)11257820
035   $a(PQKBTitleCode)TC0000336032
035   $a(PQKBWorkID)10278577
035   $a(PQKB)11609727
035   $a(PQKBManifestationID)16032677
035   $a(PQKB)22873253
035   $a(MiAaPQ)EBC448903
035   $a(MiAaPQ)EBC4037469
035   $a(DLC)  2015299086
035   $a(PPN)243291590
035   $a(OCoLC)441886965
035   $a(Perlego)1008159
035   $a(EXLCZ)991000000000773866
100   $a20081024d2009      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aCompatibility of pharmaceutical products and contact materials $esafety considerations associated with extractables and leachables /$fDennis Jenke
210   $aHoboken, N.J. $cJohn Wiley$dc2009
215   $a1 online resource (401 p.)
300   $aDescription based upon print version of record.
311 08$a9780470281765 
311 08$a0470281766 
320   $aIncludes bibliographical references and index.
327   $aNomenclature and central concepts -- Extractables, leachables, and the product life cycle -- Material screening and characterization -- The prototype stage -- The early development stage -- Late stage product development -- Submission -- Launch -- Product maintenance -- Retirement -- Focus on emerging concepts.
330   $aCompatibility of Pharmaceutical Products and Contact Materials Dennis Jenke Important safety aspects of compatibility for therapeutic products and their manufacturing systems, delivery devices, and containers Compatibility of Pharmaceutical Products and Contact Materials helps pharmaceutical, toxicology, analytical, and regulatory affairs professionals assess the safety of leachable and extractable chemicals associated with drug product packaging, manufacturing systems, and devices. The most comprehensive resource available, its coverage includes the strategies, tactics, and regul
606   $aDrugs$xContainers$xSafety measures
606   $aDrug delivery devices$xSafety measures
606   $aLeachate
606   $aExtracts
615  0$aDrugs$xContainers$xSafety measures.
615  0$aDrug delivery devices$xSafety measures.
615  0$aLeachate.
615  0$aExtracts.
676   $a615/.190289
700   $aJenke$b Dennis$01635509
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9911019332203321
996   $aCompatibility of pharmaceutical products and contact materials$94032785
997   $aUNINA